dr. J. (Jan) Westerink
Assistant Professor - medical
- Internal Medicine
Contact
Research Output (82)
A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy
Kusadasi Nuray, Sikma Maaike, Huisman Albert, Westerink Jan, Maas Coen, Schutgens Roger aug 2020, In: HemaSphere. 4 , p. e457
Intimal and medial calcification in relation to cardiovascular risk factors
Zwakenberg Sabine R., de Jong Pim A., Hendriks Eva J., Westerink Jan, Spiering Wilko, de Borst Gert J., Cramer Maarten J., Bartstra Jonas W., Doesburg Teddo, Rutters Femke, van der Heijden Amber A., Schalkwijk Casper, Schurgers Leon J., van der Schouw Yvonne T., Beulens Joline W.J., 13 jul 2020, In: PLoS ONE. 15 14 p.
The relation between healthy lifestyle changes and decrease in systemic inflammation in patients with stable cardiovascular disease
van ’t Klooster C. C., van der Graaf Y., Ridker P. M., Westerink J., Hjortnaes J., Sluijs I., Asselbergs F. W., Bots M. L., Kappelle L. J., Visseren F. L.J., mei 2020, In: Atherosclerosis. 301 , p. 37-43 7 p.
Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2
Beun Robert, Kusadasi Nuray, Sikma Maaike, Westerink Jan, Huisman Albert 1 jan 2020, In: International Journal of Laboratory Hematology. 42 , p. 19-20 2 p.
Apparent therapy-resistant hypertension as risk factor for the development of type 2 diabetes mellitus
Holtrop Joris, Spiering Wilko, Nathoe Hendrik M, De Borst Gert J, Kappelle Laurens J, De Valk Harold W, Visseren Frank L J, Westerink Jan, jan 2020, In: Journal of Hypertension. 38 , p. 45-51 7 p.
Intracranial Atherosclerotic Burden on 7T MRI Is Associated with Markers of Extracranial Atherosclerosis:The SMART-MR Study
Zwartbol M. H. T., Geerlings M. I., Ghaznawi R., Hendrikse J., van der Kolk A. G., Asselbergs F. W., Nathoe H. M., de Borst G. J., Bots M. L., Emmelot M. H., de Jong P. A., Leiner T., Lely A. T., van der Kaaij N. P., Kappelle L. J., Ruigrok Y. M., Verhaar M. C., Visseren F. L. J., Westerink J., 5 dec 2019, In: American Journal of Neuroradiology. 40 , p. 2016-2022 7 p.
Normal-range thyroid-stimulating hormone levels and cardiovascular events and mortality in type 2 diabetes
de Vries Tamar I., de Valk Harold W., van der Graaf Yolanda, de Borst Gert J., Cramer Maarten J.M., Jaap Kappelle L., Visseren Frank L.J., Westerink Jan 16 okt 2019, In: Diabetes Research and Clinical Practice. 157
The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes:A randomized, double-blind, placebo-controlled trial
Zwakenberg S. R., De Jong P. A., Bartstra J. W., Van Asperen R., Westerink J., De Valk H., Slart R. H.J.A., Luurtsema G., Wolterink J. M., De Borst G. J., Van Herwaarden J. A., Van De Ree M. A., Schurgers L. J., Van Der Schouw Y. T., Beulens J. W.J. 1 okt 2019, In: American Journal of Clinical Nutrition. 110 , p. 883-890 8 p.
Heterogeneity of treatment effects from an intensive lifestyle weight loss intervention on cardiovascular events in patients with type 2 diabetes:Data from the look AHEAD trial
De Vries Tamar I., Dorresteijn Jannick A.N., Van Der Graaf Yolanda, Visseren Frank L.J., Westerink Jan 1 okt 2019, In: Diabetes Care. 42 , p. 1988-1994 7 p.
Transcranial Doppler 24 Hours after Carotid Endarterectomy Accurately Identifies Patients Not at Risk of Cerebral Hyperperfusion Syndrome
Fassaert Leonie M.M., Immink Rogier V., van Vriesland Daniël J., de Vries Jean Paul P.M., Toorop Raechel J., Kappelle L. Jaap, Westerink Jan, Tromp Selma C., de Borst Gert J. 1 sep 2019, In: European Journal of Vascular and Endovascular Surgery. 58 , p. 320-327 8 p.